Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 19008721)

1.

Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.

Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, Tapilskaya NI, Bzhelyansky A, Reznik VA, Frolova EV, Nikitina ER, Budny GV, Longo DL, Lakatta EG, Bagrov AY.

J Hypertens. 2008 Dec;26(12):2414-25. doi: 10.1097/HJH.0b013e328312c86a.

2.

PP089. Analytical aspects of marinobufagenin and its applications in the diagnosis of preeclampsia.

Lenaerts C, Larcy C, Blankert B.

Pregnancy Hypertens. 2013 Apr;3(2):99. doi: 10.1016/j.preghy.2013.04.114. Epub 2013 Jun 6.

PMID:
26105942
3.

6B.05: SALT-SENSITIVITY OF ANGIOGENESIS INHIBITION-INDUCED BLOOD PRESSURE (BP) RISE: ROLE OF INTERSTITIAL SODIUM ACCUMULATION?

Lankhorst S, Severs D, Marko L, Rakova N, Titze J, Müller DN, Danser AH, van den Meiracker AH.

J Hypertens. 2015 Jun;33 Suppl 1:e77. doi: 10.1097/01.hjh.0000467560.57595.1c.

PMID:
26102928
4.

Defective renal dopamine function and sodium-sensitive hypertension in adult ovariectomized Wistar rats: role of the cytochrome P-450 pathway.

Di Ciano LA, Azurmendi PJ, Colombero C, Levin G, Oddo EM, Arrizurieta EE, Nowicki S, Ibarra FR.

Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1358-68. doi: 10.1152/ajprenal.00450.2014. Epub 2015 Apr 29.

PMID:
25925257
5.

Differing Effects of Resibufagenin on Cinobufatalin- versus Marinobufagenin-Induced Preeclampsia in a Rodent Model.

Puschett JB, Kumar B, Abbas MM.

Am J Perinatol. 2015 Jul;32(8):803-8. doi: 10.1055/s-0034-1396694. Epub 2014 Dec 29.

PMID:
25545447
6.

Effects of detyrosinated tubulin on Na+,K+-ATPase activity and erythrocyte function in hypertensive subjects.

Amaiden MR, Santander VS, Monesterolo NE, Nigra AD, Rivelli JF, Campetelli AN, Pie J, Casale CH.

FEBS Lett. 2015 Jan 30;589(3):364-73. doi: 10.1016/j.febslet.2014.12.022. Epub 2014 Dec 23.

PMID:
25541490
7.

Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.

Fedorova OV, Lakatta EG, Bagrov AY, Melander O.

J Hypertens. 2015 Mar;33(3):534-41; discussion 541. doi: 10.1097/HJH.0000000000000437.

PMID:
25479026
8.

Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.

Tomaschitz A, Piecha G, Ritz E, Meinitzer A, Haas J, Pieske B, Wiecek A, Rus-Machan J, Toplak H, März W, Verheyen N, Gaksch M, Amrein K, Kraigher-Krainer E, Fahrleitner-Pammer A, Pilz S.

Clin Exp Hypertens. 2015;37(2):108-15. doi: 10.3109/10641963.2014.913604. Epub 2014 Apr 30.

PMID:
24785704
9.

Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease.

Haller ST, Drummond CA, Yan Y, Liu J, Tian J, Malhotra D, Shapiro JI.

Am J Hypertens. 2014 Apr;27(4):603-9. doi: 10.1093/ajh/hpt169. Epub 2013 Sep 6.

10.

Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness.

Jablonski KL, Fedorova OV, Racine ML, Geolfos CJ, Gates PE, Chonchol M, Fleenor BS, Lakatta EG, Bagrov AY, Seals DR.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1952-9. doi: 10.2215/CJN.00900113. Epub 2013 Aug 8.

11.

Magnesium sulfate potentiates effect of DigiFab on marinobufagenin-induced Na/K-ATPase inhibition.

Zazerskaya IE, Ishkaraeva VV, Frolova EV, Solodovnikova NG, Grigorova YN, David Adair C, Fedorova OV, Bagrov AY.

Am J Hypertens. 2013 Nov;26(11):1269-72. doi: 10.1093/ajh/hpt117. Epub 2013 Jul 22.

12.

Chronic antioxidant therapy lowers blood pressure in adult but not in young Dahl salt hypertensive rats: the role of sympathetic nervous system.

Vaněčková I, Vokurková M, Rauchová H, Dobešová Z, Pecháňová O, Kuneš J, Vorlíček J, Zicha J.

Acta Physiol (Oxf). 2013 Aug;208(4):340-9. doi: 10.1111/apha.12092. Epub 2013 Apr 12.

PMID:
23480535
13.

Analytical aspects of marinobufagenin.

Lenaerts C, Demeyer M, Gerbaux P, Blankert B.

Clin Chim Acta. 2013 Jun 5;421:193-201. doi: 10.1016/j.cca.2013.02.028. Epub 2013 Mar 5. Review.

PMID:
23470428
14.

Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump.

Fedorova OV, Kashkin VA, Zakharova IO, Lakatta EG, Bagrov AY.

J Hypertens. 2012 Sep;30(9):1817-26. doi: 10.1097/HJH.0b013e328356399b.

15.

DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase inhibition.

Ishkaraeva-Yakovleva VV, Fedorova OV, Solodovnikova NG, Frolova EV, Bzhelyansky AM, Emelyanov IV, Adair CD, Zazerskaya IE, Bagrov AY.

Reprod Sci. 2012 Dec;19(12):1260-7. doi: 10.1177/1933719112447124. Epub 2012 May 30.

16.

Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies.

Macdonald-Wallis C, Lawlor DA, Fraser A, May M, Nelson SM, Tilling K.

Hypertension. 2012 Jun;59(6):1241-8. doi: 10.1161/HYPERTENSIONAHA.111.187039. Epub 2012 Apr 23.

17.

Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.

Haller ST, Kennedy DJ, Shidyak A, Budny GV, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY.

Am J Hypertens. 2012 Jun;25(6):690-6. doi: 10.1038/ajh.2012.17. Epub 2012 Mar 1.

18.

DOCA-salt hypertension does not require the ouabain-sensitive binding site of the α2 Na,K-ATPase.

Lorenz JN, Oshiro N, Loreaux EL, Lingrel JB.

Am J Hypertens. 2012 Apr;25(4):421-9. doi: 10.1038/ajh.2011.255. Epub 2012 Jan 19.

19.

Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.

Hauck C, Frishman WH.

Cardiol Rev. 2012 May-Jun;20(3):130-8. doi: 10.1097/CRD.0b013e31823c835c. Review.

PMID:
22183064
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk